Diagnosis of underlying mechanisms of diffuse microvascular bleeding allows targeted therapy.
Fries
D
D
Innerhofer
P
P
D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects / Q000627:therapeutic use; D005340:Fibrinogen / Q000032:analysis; D006402:Hematologic Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016343:Monitoring, Intraoperative / Q000379:methods; D013514:Surgical Procedures, Operative / Q000009:adverse effects*
D000933:Antifibrinolytic Agents; D000991:Antithrombins; D006490:Hemostatics; D005340:Fibrinogen; D003894:Deamino Arginine Vasopressin